Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies (Q30226488)

11 June 2017

1 reference

title

Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies (English)

1 reference

11 June 2017

0 references

1

Shayesta Dhalla

1 reference

11 June 2017

2

Gary Poole

1 reference

11 June 2017

language of work or name

English

0 references

publication date

6 July 2011

1 reference

11 June 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 June 2017

volume

29

1 reference

11 June 2017

issue

35

1 reference

11 June 2017

page(s)

5850-5859

1 reference

How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak out.

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Barriers to participating in an HIV vaccine trial: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Characteristics of volunteer participants in phase I HIV vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. Communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Recruiting London gay men into an HIV vaccine trial: Is it feasible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Perceptions of a community sample about participation in future HIV vaccine trials in south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV-1 vaccine trials among young Thai men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Correlates of HIV vaccine trial participation: an Indian perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Sexual risk factors associated with volunteering for HIV vaccine research in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Community preparedness for HIV vaccine trials in the Democratic Republic of Congo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

HIV vaccine trials: will intravenous drug users enroll?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Scaling HIV Vaccine Attitudes among Gay Men in Sydney, Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness of Chinese injection drug users to participate in HIV vaccine trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Willingness to participate in HIV vaccine trials: the impact of trial attributes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Vaccine preparedness: lessons from Lyantonde, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

A factorial survey study to assess the acceptability of HIV vaccine trial designs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

What can HIV vaccine trials teach us about future HIV vaccine dissemination?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Use of community-based participatory research in preparing low income and homeless minority populations for future HIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Knowledge and attitudes towards HIV vaccines among Soweto adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

inferred from DOI database lookup

7 January 2021

based on heuristic

Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.055

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.06.055

1 reference

11 June 2017

1 reference